| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Accounting > A Basic Introduction to Accounts Receivables |
|
Advice You - A Basic Introduction to Accounts Receivables
If one were to reduce business to the simplest terms, one would probably call it the selling of goods by one person, and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product the buying of those same goods by another. Thus, whether we pay cash or run up a tab while doing business, money has to c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hange hands during the course of a business transaction. Accounts receivables is one such type of a business transaction lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. . It refers to the way of dealing with amounts of money that are owed to a business by its customer. On the balance sheet here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of a company, accounts receivable refer to the amount of money that a customer owes it. Accounts receivables are also ref d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro erred to as trade receivables, which makes the concept a little clearer. As this is a debt related amount, it appears un ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc der the category of current assets on the balance sheet of the company. An accounts receivables transaction is generally easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi carried out by means of an invoice which is sent to the customer with the aim of informing him of the duration within whi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ch the debt amount must be paid off. The term within which the debt has to be paid may be thirty days, forty-five days, s and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ixty days, or even as much as ninety days. However, the duration of the debt depends entirely on the debtor and the credi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi or. Various payment practices may be followed. These practices may be determined by the various industry standards. They ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a may also be colored by the financial status of the debtor, or affected by the company's corporate policy. Larger busine dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ss organizations usually have to resort to the development of an entire accounts receivables department to look into the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin various kinds and amounts of debts that its customers owe it. A sales ledger is usually used to record transactions that tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ertain to accounts receivables. Anyone who is starting out on a new business venture would have to learn about the vario t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel us kinds of accounting terms and practices that are carried on within various industries. To get into a business undertak ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ing without adequate study of the various accounting practices would be committing professional hara-kiri. Accounts recei y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ables is only one of the many kinds of transactions that prevail in a business setting. No matter what noble work you ho . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de pe to do through your business, ultimately you would want it to be financially sound. So, you should make sure to find ou elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t about the many financial transactions that will enter into the picture once you start selling your products or services tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Beginning a Six Sigma Initiative An Alternative to Venture Capital in the Food and Beverage Industry
|